Stable supply of reliable and safe products and services
First written in FY2016. 11 of 12 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025RestatedAnnual report
「As uncertainty over the supply of pharmaceuticals became a social issue, we complied with the Guidelines for Improving Distribution and worked to maintain a stable supply in fulfilling our mission as social infrastructure.」
Even amid concerns over the pharmaceutical supply becoming a social issue, the company has demonstrated its commitment to complying with the Guidelines for Improving Distribution and maintaining a stable supply. - FY2024-Q1RestatedAnnual report
「The Group is working to maintain a stable supply of pharmaceuticals and other products while ensuring the safety of its business partners and Group employees, in order to fulfill its mission as social infrastructure handling products related to human life.」
As social infrastructure handling products essential to life, we have reaffirmed our policy of continuing to ensure safety and maintain a stable supply. - FY2023-Q2RestatedAnnual report
「As a social infrastructure provider handling products essential to life, we are taking measures to prevent the further spread of infection while ensuring the safety of our business partners and Group employees and working to maintain a stable supply of pharmaceuticals and other products.」
Even during the infectious disease outbreak, we continue to prevent the further spread of infection, ensure the safety of business partners and employees, and maintain a stable supply of pharmaceuticals and other products. - FY2022-Q3RestatedAnnual report
「During the first nine months of the current fiscal year, as the spread of COVID-19 continued, the Group, as social infrastructure handling products related to human life and health, took measures to prevent the spread of infection and worked to ensure a stable supply of pharmaceuticals and other products while securing the safety of its business partners and Group employees.」
Even during the spread of infectious diseases, the Group has continued to ensure the safety of business partners and employees and maintain a stable supply of pharmaceuticals and other products. - FY2022-Q2RestatedAnnual report
「During the cumulative second quarter of the fiscal year under review, as the spread of COVID-19 continued, the Group took measures to prevent the spread of infection and worked to ensure a stable supply of pharmaceuticals and other products while ensuring the safety of business partners and Group employees, in order to fulfill its mission as social infrastructure handling life-related products.」
Even during the spread of infectious diseases, the Group has continued infection prevention measures, ensured the safety of business partners and employees, and maintained a stable supply of pharmaceuticals and other products. - FY2022-Q1RestatedAnnual report
「As the spread of COVID-19 continued, the Group, as social infrastructure handling products related to human life and health, took measures to prevent the spread of infection and worked to ensure a stable supply of pharmaceuticals and other products while securing the safety of its business partners and Group employees.」
Even during the spread of infectious diseases, the Group has continued infection prevention measures, ensured the safety of business partners and employees, and maintained a stable supply of pharmaceuticals and other products. - FY2021RestatedAnnual report
「The Group took measures to prevent the spread of infection and worked to ensure a stable supply of pharmaceuticals and other products while securing the safety of its business partners and Group employees.」
Even during the spread of infectious diseases, the Group has continued infection prevention measures, ensured the safety of business partners and employees, and maintained a stable supply of pharmaceuticals and other products. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year under review, as the COVID-19 pandemic continued, the Group took measures to prevent the spread of infection and worked to ensure a stable supply of pharmaceuticals and other products while ensuring the safety of business partners and Group employees, in order to fulfill its mission as social infrastructure handling life-related products.」
Even during the spread of infectious diseases, the Group has continued to ensure the safety of business partners and employees and maintain a stable supply of pharmaceuticals and other products. - FY2021-Q2RestatedAnnual report
「As the spread of COVID-19 continued, the Group, as social infrastructure handling products related to human life and health, took measures to prevent the spread of infection and worked to ensure a stable supply of pharmaceuticals and other products while securing the safety of its business partners and Group employees.」
Even during the spread of infectious diseases, the Group has continued to ensure safety and maintain a stable supply of pharmaceuticals and other products as social infrastructure handling products related to human life and health. - FY2021-Q1RestatedAnnual report
「As a social infrastructure provider handling products related to human life and health, the Group is taking measures to prevent the spread of infection and working to ensure a stable supply of pharmaceuticals and other products while securing the safety of its business partners and Group employees.」
Even during the spread of COVID-19, the Group has continued to ensure safety and maintain a stable supply of pharmaceuticals and other products as social infrastructure handling products related to human life and health. - FY2019RestatedAnnual report
「We will always provide reliable products and services and strive to improve customer satisfaction.」
The continued provision of reliable, safe and sincere products and services remains a commitment under the Group philosophy. - FY2016First statedAnnual report
「We consistently provide safe, reliable products and services that meet our customers’ needs.」
As a life and health-related company, the Group maintains customer satisfaction and the reliable, safe and stable supply of products and services as ongoing commitments.